AbbVie corporate sign displayed on a sleek building with glass and metal design.

PARTNERSHIPS

10 Jul 2025

AbbVie Goes All In on In-Body Gene Therapy

AbbVie acquires Capstan to unlock in-vivo gene delivery and transform autoimmune treatment with faster, easier therapies.

CRISPR-themed interior wall with bright lettering in a contemporary research building.

RESEARCH

4 Jul 2025

One Injection, Decades of Heart Protection?

CRISPR therapy cuts LDL by 86% in a single dose, hinting at a future where gene editing replaces daily heart meds.

Abstract DNA double helix with glowing edit points in a dark scientific background.

INNOVATION

24 Jun 2025

One-Shot CRISPR Could Rewrite Blood Disorder Care

Editas’ single-dose CRISPR therapy could make sickle cell treatment faster, cheaper, and far more accessible.

Close-up of pipette and petri dish over a printed DNA pattern in a lab setting.

REGULATORY

17 Jun 2025

FDA Accelerates Cell and Gene Therapy Reviews, Emphasizing Regulatory Flexib

FDA speeds cell and gene therapy reviews, aiming for faster access without lowering safety standards.

Abstract CRISPR gene-editing illustration featuring DNA strands and illuminated edit points.

INNOVATION

5 Jun 2025

CRISPR Developers Eye Safer Path to the Clinic

Sector turns to next-generation delivery and risk controls as in vivo gene editing moves toward wider clinical use

Baby with feeding tube sticker supported by gloved clinicians in a medical setting.

PARTNERSHIPS

21 May 2025

Tiny Particles, Big Genetic Win!

CHOP, Penn, and Acuitas use lipid nanoparticles for rare genetic disorder, bypassing viral vectors for the first time in the US.

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.